16 related articles for article (PubMed ID: 3690546)
1. Phase II evaluation of spirogermanium in malignant melanoma: a Southwest Oncology Group Study.
Goodwin JW; Kopecky K; Slavik M; Tranum BL; Balcerzak SP; Fletcher WS; Costanzi JJ
Cancer Treat Rep; 1987 Oct; 71(10):985-6. PubMed ID: 3652061
[No Abstract] [Full Text] [Related]
2. [Metastatic cancer of the prostate: phase II study of spirogermanium (NSC 192965)].
Bui NB; Chauvergne J; Brunet R; Richaud P; Hoerni B; Lagarde C; Le Guillou M
Bull Cancer; 1986; 73(1):65-7. PubMed ID: 3779124
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of spirogermanium in breast adenocarcinoma: a Cancer and Leukemia Group B Study.
Budman DR; Ginsberg S; Perry M; Weinberg V; Schein P; Hanson J; Coleman M; Wood W
Cancer Treat Rep; 1982 Aug; 66(8):1667-8. PubMed ID: 7105058
[No Abstract] [Full Text] [Related]
4. Therapy for advanced renal cell cancer with spirogermanium: a Southwest Oncology Group Study.
Saiers JH; Slavik M; Stephens RL; Crawford ED
Cancer Treat Rep; 1987 Feb; 71(2):207-8. PubMed ID: 3802117
[No Abstract] [Full Text] [Related]
5. Phase II study of spirogermanium in metastatic prostate cancer.
Dexeus FH; Logothetis C; Samuels ML; Hossan B
Cancer Treat Rep; 1986 Sep; 70(9):1129-30. PubMed ID: 3742495
[No Abstract] [Full Text] [Related]
6. Phase II study of spirogermanium in advanced adenocarcinoma of the prostate: a Southwest Oncology Group Study.
Saiers JH; Blumenstein B; Slavik M; Costanzi JH; Crawford ED
Cancer Treat Rep; 1987 Dec; 71(12):1305-6. PubMed ID: 3690546
[No Abstract] [Full Text] [Related]
7. [Evaluation of health promotive effect of organometallic germanium compounds].
Wang YL
Zhonghua Yu Fang Yi Xue Za Zhi; 1994 Nov; 28(6):372-4. PubMed ID: 7867458
[No Abstract] [Full Text] [Related]
8.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
